The Next Trip: Developing the Second Generation of Psychedelics and Their Analogs for Targeted Medical Use
.custom-column-left-text {
float: left;
width: 50%;
padding-right: 10px;
}
.custom-column-right-text {
float: right;
width: 45%;
text-align:center;
}
@media only screen and (max-width: 600px) {
.custom-column-left-text,
.custom-column-right-text,
.custom-column-flc-ebook-text {
float:none;
width:80%;
margin:0 auto;
}
}
Following decades of stagnation, the field of psychedelic research is being revitalized by the investigation of their potential benefit for mainstream psychiat
Method for Surgical Closing of Muscle Biopsy Sites on Nonhuman Primates in Group Housing
Using Anti-Drug-Antibody Screening Assay to Resolve Selectivity Issues in Toxicokinetic Ligand-Binding Assay
Mitigation of On-Column Conversion of Ivabradine to Desmethylivabradine Metal Chelation With Citric Acid Modifier
Dual Purpose of a Cell-Based Assay for an Agonist of the GLP-2 Receptor
Development of an Oligonucleotide Drug Immunogenicity Assay: A Case for the Characterization of the Immune Response